Joanna Lachowicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joanna Lachowicz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Szopa
Medical University of Lublin
1 shared publication - Anna Serefko
Medical University of Lublin
1 shared publication - Ewelina Rostkowska
Beauty Salon “Clarie Beauty”, Pułaskiego 26, 20-461 Lublin, Poland
1 shared publication - Jarosław Szponar
Toxicology Clinic, Faculty of Medicine, Medical University of Lublin, 100 Krasnik Avenue, 20-550 Lublin, Poland
1 shared publication - Karolina Niedziałek
Student’s Scientific Circle at Laboratory of Preclinical Testing, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland
1 shared publication - Katarzyna Świąder
Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland
1 shared publication
Latest Publications
- Open Access
Zebrafish as an Animal Model for Testing Agents with Antidepressant Potential
Depression is a serious mental disease that, according to statistics, affects 320 million people worldwide. Additionally, a current situation related to the COVID-19 pandemic has led to a significant deterioration of mental health in people around the world. So far, rodents have been treated as basic animal models used in studies on this disease, but in recent years, Danio rerio has emerged as a new organism that might serve well in preclinical experiments. Zebrafish have a lot of advantages, such as a quick reproductive cycle, transparent body during the early developmental stages, high genetic and physiological homology to humans, and low costs of maintenance. Here, we discuss the potential of the zebrafish model to be used in behavioral studies focused on testing agents with antidepressant potential.
Open AccessZebrafish as an Animal Model for Testing Agents with Antidepressant Potential
Depression is a serious mental disease that, according to statistics, affects 320 million people worldwide. Additionally, a current situation related to the COVID-19 pandemic has led to a significant deterioration of mental health in people around the world. So far, rodents have been treated as basic animal models used in studies on this disease, but in recent years, Danio rerio has emerged as a new organism that might serve well in preclinical experiments. Zebrafish have a lot of advantages, such as a quick reproductive cycle, transparent body during the early developmental stages, high genetic and physiological homology to humans, and low costs of maintenance. Here, we discuss the potential of the zebrafish model to be used in behavioral studies focused on testing agents with antidepressant potential.